Frontiers in pharmacology
Commentary: CU06-1004 inhibits the progression of chronic colitis and colitis-associated colorectal cancer by suppressing inflammation.
Wentao Guo, Yun Wang, Danqin Fang, Zhihui Zeng
Published: 202510.3389/fphar.2025.1750070
No abstract available for this study.